 |
|
|
|
| Bayer Group Consolidated Statements of Income |
 | 3 of 34 |  |
|
|
| |
| |
Note |
20041 |
2005 |
| EUR million |
|
|
|
| Net sales |
[8] |
23,278 |
27,383 |
| Cost of goods sold |
|
(12,421) |
(15,027) |
| Gross profit |
|
10,857 |
12,356 |
| |
|
|
|
| Selling expenses |
[9] |
(5,240) |
(5,713) |
| Research and development expenses |
[10] |
1,927 |
(1,886) |
| General administration expenses |
|
(1,421) |
(1,444) |
| Other operating income |
[11] |
740 |
794 |
| Other operating expenses |
[12] |
(1,134) |
(1,295) |
| Operating result [EBIT] |
[14] |
1,875 |
2,812 |
| |
|
|
|
| Equity-method loss |
[15.1] |
(139) |
(10) |
| Non-operating income |
|
483 |
634 |
| Non-operating expenses |
|
(997) |
(1,237) |
| |
|
|
|
| Non-operating result |
[15] |
(653) |
(613) |
| |
|
|
|
| Income before income taxes |
|
1,222 |
2,199 |
| |
|
|
|
| Income taxes |
[16] |
(473) |
(641) |
| |
|
|
|
| Income from continuing operations after taxes |
|
749 |
1,558 |
| |
|
|
|
| Income (loss) from discontinued operations after taxes |
[7.2] |
(67) |
37 |
| |
|
|
|
| Income after taxes |
|
682 |
1,595 |
| of which attributable to minority interest |
[17] |
(3) |
(2) |
| of which attributable to Bayer AG stockholders (net income) |
|
685 |
1,597 |
| |
|
|
|
| Earnings per share (EUR) |
|
0.94 |
2.19 |
| From continuing operations |
[18] |
1.03 |
2.14 |
| Basic |
|
1.03 |
2.14 |
| Diluted |
|
1.03 |
2.14 |
| From continuing and discontinued operations |
[18] |
0.94 |
2.19 |
| Basic |
|
0.94 |
2.19 |
| Diluted |
|
0.94 |
2.19 |
1 2004 figures restated
|
| |
| |
top
E-mail this page
Download Acrobat Reader